company is developing several mid-to-late-
stage therapies, including a copper-binding agent for Wilson disease, an anti... as well as several early-
stage therapies, including one for light chain (AL) amyloidosis, a second oral Factor D inhibitor and a third... -
Voir cette offre d'emploi